Rita Dichtiar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rita Dichtiar has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Lital Keinan-Boker
2 shared publicationsTamy Shohat
Israel Center for Disease Control, Israel Ministry of Health, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel
2 shared publicationsAnneke Ifrah
Israel Center for Disease Control, Israel Ministry of Health, Israel
1 shared publication- Asher Ornoy
Department of Morphological Sciences and Teratology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel
1 shared publication Barbara Silverman
Israel Center for Disease Control, Israel Ministry of Health, Israel
1 shared publication- Dror Ben Leviner
Rabin Medical Center
1 shared publication
Latest Publications
- 2 February 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (4) , 760-768
Outcomes of cardiac surgery in patients with end‐stage renal disease: Insights from the Israel national registries
Background End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. Methods The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. Results One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2–18.2), MVR procedure (HR = 1.5, 95% CI; 1.04–2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2–2.04). Conclusions Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
- 2 February 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (4) , 760-768
Outcomes of cardiac surgery in patients with end‐stage renal disease: Insights from the Israel national registries
Background End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. Methods The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. Results One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2–18.2), MVR procedure (HR = 1.5, 95% CI; 1.04–2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2–2.04). Conclusions Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
- 1 December 2018
- Published by Elsevier in Cancer Epidemiology
- Vol. 57, 127-133
Risk of second primary neoplasm and mortality in childhood cancer survivors based on a national registry database
- 1 December 2018
- Published by Elsevier in Cancer Epidemiology
- Vol. 57, 127-133
Risk of second primary neoplasm and mortality in childhood cancer survivors based on a national registry database
- 19 October 2012
- Published by Springer Nature in Pediatric Research
- Vol. 73 (1) , 111-119
Lack of severe long-term outcomes of acute, subclinical B1 deficiency in 216 children in Israel exposed in early infancy
A vitamin B(1)-deficient soy-based infant formula was marketed in Israel in 2003, exposing infants to clinical or subclinical B(1) deficiency. We investigated whether subclinical B(1) deficiency in early infancy had medical, neurodevelopmental, or cognitive effects at 3-5 y of age. A historical prospective cohort study was conducted consisting of four groups: "exposed," consuming a B(1)-deficient soy-based formula exclusively for four consecutive weeks or longer; "control," consuming no soy-based formula; "mixed," consuming the formula nonexclusively or exclusively for less than four consecutive weeks; and "other," consuming soy-based formulas other than Remedia. Participants were evaluated by medical examination, Stanford-Binet (SB) intelligence test, sensory profile evaluation, and Conners scales (attention deficit disorder/attention deficit and hyperactivity disorder (ADD/ADHD)). Following adjustment for gender, age, and maternal education, there were no significant differences among the four groups on the mean SB scores, on the verbal and nonverbal scores, or in the proportion of children in each group with scores <90. A significantly higher proportion of exposed children as compared with control children had an impaired sensory profile and scores on the Conners scales (ADD/ADHD), but these proportions were also high in the "other" and "mixed" groups. The results do not support an association between subclinical B(1) deficiency in infancy and long-term development.
- 19 October 2012
- Published by Springer Nature in Pediatric Research
- Vol. 73 (1) , 111-119
Lack of severe long-term outcomes of acute, subclinical B1 deficiency in 216 children in Israel exposed in early infancy
A vitamin B(1)-deficient soy-based infant formula was marketed in Israel in 2003, exposing infants to clinical or subclinical B(1) deficiency. We investigated whether subclinical B(1) deficiency in early infancy had medical, neurodevelopmental, or cognitive effects at 3-5 y of age. A historical prospective cohort study was conducted consisting of four groups: "exposed," consuming a B(1)-deficient soy-based formula exclusively for four consecutive weeks or longer; "control," consuming no soy-based formula; "mixed," consuming the formula nonexclusively or exclusively for less than four consecutive weeks; and "other," consuming soy-based formulas other than Remedia. Participants were evaluated by medical examination, Stanford-Binet (SB) intelligence test, sensory profile evaluation, and Conners scales (attention deficit disorder/attention deficit and hyperactivity disorder (ADD/ADHD)). Following adjustment for gender, age, and maternal education, there were no significant differences among the four groups on the mean SB scores, on the verbal and nonverbal scores, or in the proportion of children in each group with scores <90. A significantly higher proportion of exposed children as compared with control children had an impaired sensory profile and scores on the Conners scales (ADD/ADHD), but these proportions were also high in the "other" and "mixed" groups. The results do not support an association between subclinical B(1) deficiency in infancy and long-term development.
- 15 April 2011
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (8_Suppleme) , 3714
Abstract 3714: Breast cancer trends in Israeli Jewish and Arab women 1996-2007
Background: Breast cancer is the most common malignancy in Israeli Jewish and Arab women, but the disease trends in these two population groups have not been re-examined in recent years. The Israel National Cancer Registry (INCR) and the Israel Center for Disease Control (ICDC) collaborate to provide periodic population-based summary data on cancer incidence, mortality and survival. Methods: Data were obtained from the INCR, the ICDC and the National Bureau of Statistics. The rates presented are age-adjusted to the world standard population. Time trends are presented using the moving average method. Relative survival (i.e., observed survival among cancer patients divided by the expected survival in the general population with the same age, sex and ethnicity distribution) was calculated for the diagnosis years 1996-2003. Data from the Knowledge, Attitudes and Practices (KAP) surveys carried out in 2000, 2002, 2004, 2006 and 2008 were analyzed to determine proportions of women that reported undergoing a screening mammogram in the previous two years. Results: From 1996 through 2007, age-adjusted breast cancer incidence rates (per 100,000) increased from 96.7 to 99.8 (3%, ns*) in Jewish women and from 38.6 to 79.2 (105%, p=0.0001) in Arab women. The p-value for between-populations trend differences (p-value ‘between′) was Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3714. doi:10.1158/1538-7445.AM2011-3714
- 15 April 2011
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (8_Suppleme) , 3714
Abstract 3714: Breast cancer trends in Israeli Jewish and Arab women 1996-2007
Background: Breast cancer is the most common malignancy in Israeli Jewish and Arab women, but the disease trends in these two population groups have not been re-examined in recent years. The Israel National Cancer Registry (INCR) and the Israel Center for Disease Control (ICDC) collaborate to provide periodic population-based summary data on cancer incidence, mortality and survival. Methods: Data were obtained from the INCR, the ICDC and the National Bureau of Statistics. The rates presented are age-adjusted to the world standard population. Time trends are presented using the moving average method. Relative survival (i.e., observed survival among cancer patients divided by the expected survival in the general population with the same age, sex and ethnicity distribution) was calculated for the diagnosis years 1996-2003. Data from the Knowledge, Attitudes and Practices (KAP) surveys carried out in 2000, 2002, 2004, 2006 and 2008 were analyzed to determine proportions of women that reported undergoing a screening mammogram in the previous two years. Results: From 1996 through 2007, age-adjusted breast cancer incidence rates (per 100,000) increased from 96.7 to 99.8 (3%, ns*) in Jewish women and from 38.6 to 79.2 (105%, p=0.0001) in Arab women. The p-value for between-populations trend differences (p-value ‘between′) was Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3714. doi:10.1158/1538-7445.AM2011-3714